Detail about Coromandel International Ltd.

 Coromandel International Limited is a limited company incorporated in India, equity shares of which are listed on the Bombay Stock Exchange and the National Stock Exchange in India. Its parent company is E.I.D.- Parry( India) Limited. The Company is engaged in the business of ranch inputs comprising fertilizer, crop protection, specialty nutrients, and organic compost. 

 The business area of the company 

 The Company, India’s second largest Phosphatic toxin player, is in the business parts of Diseases, Specialty Nutrients, Crop Protection, and Retail. In its bid to be a complete factory nutrition results Company, Coromandel has also introduced a range of Specialty Nutrient products including Organic Diseases. The Crop Protection business produces germicides, pesticides, and dressings, and requests these products in India and across the globe. Coromandel is the second largest manufacturer of Malathion and only the alternate manufacturer of Phenthoate. 

Brands

These are the brands of Coromandel International Ltd.

 Products & Services 

•  Fertilisers 
•  Crop Protection 
•  thing Nutrients 

 Awards and Recognitions 

 2019- 20 

• CII Exim Business Excellence Platinum Bracket 
• Dun & Bradstreet Corporate Award 
• Award of Excellence for Voice Magazine and CSR Brochure by the Academy of Interactive and Visual trades, New York 
• CSR Best commercial in health by CSR times 
• CSR Award CSR Best overall excellence by Zee 
• Vizag and Ennore units have won the CII EHS Excellence Award from Southern Region and have been rated 3 stars. 

Peers

Strengths

• The company has shown a good profit growth of 25.54% over the past 3 years.
• The company has significantly decreased its debt by 1.17 Cr.
• Company has been maintaining healthy ROE of 26.39% over the past 3 years.
• Company has been maintaining a healthy ROCE of 31.37% over the past 3 years.
• Company is virtually debt free.
• Company has a healthy Interest coverage ratio of 26.61.
• The company has an efficient Cash Conversion Cycle of 17.58 days.
• The company has good cash flow management; CFO/PAT stands at 1.71.
• The company has a high promoter holding of 57.48%.

 Limitations

• The company has shown poor revenue growth of 13.07% over the past 3 years.